| Sep.16 (Wed) | Sep.17 (Thur) | Sep.18 (Fri) | |
|---|---|---|---|
| Rm. 401 |
Opening Ceremony & 11:00~12:30 |
APEC Harmonization Center Biosimilar Workshop Track 7 - Special Track |
 |
The Opportunities and Challenges of Biological Medicines 09:00~10:30Session1 |
|||
Regulatory Issues on Biosimilars 11:00~12:30Session2 |
|||
Regulatory Landscape on Biosimilars 14:00~16:00Session3 |
|||
| Rm. 307 |
BioIndustry in UK & Korea Track 1 - Special Track |
BioIndustry in UK & Korea Track 1 - Special Track |
u-Health Track 12 |
Microfluidics System 14:00~16:00Session1 |
Stem Cell and Biologics 10:00~12:00Session3 |
Policies and Vision 10:00~12:00Session1 |
|
High Throughput Analysis for Diagnosis and Drug Discovery 16:20~18:20Session2 |
UK/Korea Bio-Opportunities 13:00~15:30Session4 |
Technology and Standardization 13:00~15:00Session2 |
|
Business Models 15:20~17:20Session3 |
|||
| Rm. 308 |
Issues to Address in Life Science BD & Funding Track 2 |
Regenerative Medicine Track 8 |
Recent Trends on Biochip Technology Track 13 |
Update on Changing Trends in Venture Investments 14:00~16:00Session1 |
Recent Advances of Stem Cell 10:00~12:00Session1 |
Recent Progress in Protein and DNA Chips 10:00~12:00Session1 |
|
Critical Issues for Successful IR of Life Science Venture Companies 16:20~18:20Session2 |
Global Development Trends for Cell Therapy 13:00~15:00Session2 |
Nano and Biomedical Sensor Technologies 13:00~15:00Session2 |
|
Recent Advances of Tissue Engineering 15:20~17:20Session3 |
Microfluidic Chips for Cells 15:20~17:20Session3 |
||
| Rm. 317 |
Technology Transfer and Licensing Track 3 |
Technology Transfer and Licensing Track 3 |
Clinical Drug Development Track 14 |
Building and Enforcing IP Value in Korea 14:00~16:00Session1 |
|
Early Phase Product Development 10:00~12:00Session1 |
|
The Journey from Discovery to the Market in the Life Sciences 16:20~18:20Session2 |
Supporting Activities for Technology Commercialization 13:00~15:00Session3 |
New Tools for Early Phase Clinical Drug Development 13:00~15:00Session2 |
|
View of Negotiation for Investment & Cooperation 15:20~17:20Session4 |
Strategies for Successful Development of Biopharmaceuticals 15:20~17:20Session3 |
||
| Rm. 318 |
Traditional Medicine Track 4 - Special Track |
Pharmaceutical Strategy for Incrementally Modified Drug Track 9 |
Bioactive Medical Implants Track 15 |
Recent Trends of R&D for Traditional Medicine in East-Asia 14:00-16:10Session1 |
Efficient Drug Delivery for IMD Strategies 10:00~12:00Session1 |
Biocompatible Implants in Medicine 10:00~12:00Session1 |
|
Recent Policy Trends of Traditional Medicine in East-Asia 16:30-18:15Session2 |
IMD Strategies for Biopharmaceuticals 13:00~15:00Session3 |
Cardiovascular Implants 13:00~15:00Session2 |
|
Advanced IMD Technologies for Next Generations 15:20~17:20Session3 |
Skeletal (Spinal, Orthopedic, and Dental) Implants 15:20~17:20Session3 |
||
| Rm. 327 |
Korea-Scotland Joint Symposium Track 5 - Special Track |
National Innovative Strategies for the Effective Control of World Generic Drug Market Track 10 |
Regulatory and GMP Compliance Track 16 |
Welcome Speech 14:00~14:05 |
Innovative and Specific Strategy for the Participation of Korean Generic Industry for the World-market 10:00~12:00Session1 |
Updated Regulatory Issues for Biologicals 10:00~12:00Session1 |
|
Diabetes and Pharmacogenomics 14:05~16:05Session1 |
Market Analysis and Measures for Korean Generic Drug Export to the World Market 13:00~15:00Session2 |
GMP Facility Design and Operation 13:00~15:00Session2 |
|
Diabetes and Therapeutics 16:25~18:25Session2 |
For the Development of Generic Drug Patent Strategy 15:20~17:50Session3 |
QC/QA 15:20~17:20Session3 |
|
| Hall E1 & E2 |
Vaccine Track 17 |
||
Vaccine Industry in Asia 10:00~12:00Session1 |
|||
Prospective Vaccine R&D 13:00~15:30Session2 |
|||
|
|||
| Rm. 301 |
Next-generation Sequencing Track 18 |
||
Application of Next-generation Sequencing to Personal Genomics 10:00~12:00Session1 |
|||
The Present of 13:00~15:00Session2 |
|||
Introduction of Next-generation Sequencing Technology to Personal 15:20~17:20Session3 |
|||
| Rm. 402 |
Recent Advances of Stem Cell Differentiation Track 6 |
Therapeutic Antibody Track 11 |
Botanical New Drug Discovery and Development Track 19 |
Cell Differentiation from Human ES Cells 14:00~16:00Session1 |
Therapeutic Antibody 1 10:00~12:00Session1 |
Development of Botanical New Drug 10:00~12:30Session1 |
|
Tissue Specific Stem Cell and Cell Reprogramming 16:20~18:20 Session2 |
Therapeutic Antibody 2 13:00~15:00Session2 |
Regulation of Botanical Products 13:30~15:30Session2 |
|
Therapeutic Antibody 3 15:20~17:50Session3 |
Global Market of Botanical Products 15:50~17:20Session3 |
||
